Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2689 to 2700 of 2709 entries
Sorted by: Best Match Show Resources per page
Diagnostic accuracy of 64-slice computed tomography coronary angiography: a flawed comparison.

Journal of the American College of Cardiology

Nicol ED, Stirrup J, Padley SP, Rubens MB.
PMID: 19422994
J Am Coll Cardiol. 2009 May 12;53(19):1824-5; author reply 1825-6. doi: 10.1016/j.jacc.2009.01.062.

No abstract available.

Cite
Nicol ED, Stirrup J, Padley SP, et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a flawed comparison. J Am Coll Cardiol. 2009;53(19):1824-5; author reply 1825-6doi: 10.1016/j.jacc.2009.01.062.
Nicol, E. D., Stirrup, J., Padley, S. P., & Rubens, M. B. (2009). Diagnostic accuracy of 64-slice computed tomography coronary angiography: a flawed comparison. Journal of the American College of Cardiology, 53(19), 1824-5; author reply 1825-6. https://doi.org/10.1016/j.jacc.2009.01.062
Nicol, Edward D, et al. "Diagnostic accuracy of 64-slice computed tomography coronary angiography: a flawed comparison." Journal of the American College of Cardiology vol. 53,19 (2009): 1824-5; author reply 1825-6. doi: https://doi.org/10.1016/j.jacc.2009.01.062
Nicol ED, Stirrup J, Padley SP, Rubens MB. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a flawed comparison. J Am Coll Cardiol. 2009 May 12;53(19):1824-5; author reply 1825-6. doi: 10.1016/j.jacc.2009.01.062. PMID: 19422994.
Copy Download .nbib Format: NLM
Comparison of prediction accuracies between mathematical models to make projections of confirmed cases during the COVID-19 pandamic by country/region.

Medicine

Tsai KT, Chien TW, Lin JK, Yeh YT, Chou W.
PMID: 34918666
Medicine (Baltimore). 2021 Dec 17;100(50):e28134. doi: 10.1097/MD.0000000000028134.

BACKGROUND: The COVID-19 pandemic caused >0.228 billion infected cases as of September 18, 2021, implying an exponential growth for infection worldwide. Many mathematical models have been proposed to predict the future cumulative number of infected cases (CNICs). Nevertheless, none...

Cite
Tsai KT, Chien TW, Lin JK, et al. Comparison of prediction accuracies between mathematical models to make projections of confirmed cases during the COVID-19 pandamic by country/region. Medicine (Baltimore). 2021;100(50):e28134doi: 10.1097/MD.0000000000028134.
Tsai, K. T., Chien, T. W., Lin, J. K., Yeh, Y. T., & Chou, W. (2021). Comparison of prediction accuracies between mathematical models to make projections of confirmed cases during the COVID-19 pandamic by country/region. Medicine, 100(50), e28134. https://doi.org/10.1097/MD.0000000000028134
Tsai, Kang-Ting, et al. "Comparison of prediction accuracies between mathematical models to make projections of confirmed cases during the COVID-19 pandamic by country/region." Medicine vol. 100,50 (2021): e28134. doi: https://doi.org/10.1097/MD.0000000000028134
Tsai KT, Chien TW, Lin JK, Yeh YT, Chou W. Comparison of prediction accuracies between mathematical models to make projections of confirmed cases during the COVID-19 pandamic by country/region. Medicine (Baltimore). 2021 Dec 17;100(50):e28134. doi: 10.1097/MD.0000000000028134. PMID: 34918666; PMCID: PMC8677971.
Copy Download .nbib Format: NLM
How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays.

Journal of bioinformatics and computational biology

Deo A, Carlsson J, Lindlöf A.
PMID: 22084014
J Bioinform Comput Biol. 2011 Dec;9(6):795-812. doi: 10.1142/s0219720011005793.

Low-density arrays for quantitative real-time PCR (qPCR) are increasingly being used as an experimental technique for miRNA expression profiling. As with gene expression profiling using microarrays, data from such experiments needs effective analysis methods to produce reliable and high-quality...

Cite
Deo A, Carlsson J, Lindlöf A. How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays. J Bioinform Comput Biol. 2011;9(6):795-812doi: 10.1142/s0219720011005793.
Deo, A., Carlsson, J., & Lindlöf, A. (2011). How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays. Journal of bioinformatics and computational biology, 9(6), 795-812. https://doi.org/10.1142/s0219720011005793
Deo, Ameya, et al. "How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays." Journal of bioinformatics and computational biology vol. 9,6 (2011): 795-812. doi: https://doi.org/10.1142/s0219720011005793
Deo A, Carlsson J, Lindlöf A. How to choose a normalization strategy for miRNA quantitative real-time (qPCR) arrays. J Bioinform Comput Biol. 2011 Dec;9(6):795-812. doi: 10.1142/s0219720011005793. PMID: 22084014.
Copy Download .nbib Format: NLM
Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters.

Journal of biopharmaceutical statistics

Soulakova JN.
PMID: 21516561
J Biopharm Stat. 2011 Jul;21(4):635-49. doi: 10.1080/10543406.2011.551328.

In this paper several multiple testing procedures are discussed with respect to the problem of detecting combination drug superiority for a bifactorial design with monotone gains. The testing methods include the generalized maximum test procedure (GMAXP) proposed by Soulakova...

Cite
Soulakova JN. Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters. J Biopharm Stat. 2011;21(4):635-49doi: 10.1080/10543406.2011.551328.
Soulakova, J. N. (2011). Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters. Journal of biopharmaceutical statistics, 21(4), 635-49. https://doi.org/10.1080/10543406.2011.551328
Soulakova, Julia N. "Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters." Journal of biopharmaceutical statistics vol. 21,4 (2011): 635-49. doi: https://doi.org/10.1080/10543406.2011.551328
Soulakova JN. Comparison of gatekeeping and other testing methods for identifying superior drug combinations in bifactorial designs with isotonic parameters. J Biopharm Stat. 2011 Jul;21(4):635-49. doi: 10.1080/10543406.2011.551328. PMID: 21516561.
Copy Download .nbib Format: NLM
Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0.

Radiographics : a review publication of the Radiological Society of North America, Inc

Chalian H, Töre HG, Horowitz JM, Salem R, Miller FH, Yaghmai V.
PMID: 22084190
Radiographics. 2011 Nov-Dec;31(7):2093-105. doi: 10.1148/rg.317115050.

Improvements in radiologic imaging technology and therapeutic options available for management of tumors have necessitated the revision of guidelines for the imaging-based assessment of tumor response to therapy. The purpose of this article is to familiarize radiologists with the...

Cite
Chalian H, Töre HG, Horowitz JM, et al. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0. Radiographics. 2011;31(7):2093-105doi: 10.1148/rg.317115050.
Chalian, H., Töre, H. G., Horowitz, J. M., Salem, R., Miller, F. H., & Yaghmai, V. (2011). Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0. Radiographics : a review publication of the Radiological Society of North America, Inc, 31(7), 2093-105. https://doi.org/10.1148/rg.317115050
Chalian, Hamid, et al. "Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0." Radiographics : a review publication of the Radiological Society of North America, Inc vol. 31,7 (2011): 2093-105. doi: https://doi.org/10.1148/rg.317115050
Chalian H, Töre HG, Horowitz JM, Salem R, Miller FH, Yaghmai V. Radiologic assessment of response to therapy: comparison of RECIST Versions 1.1 and 1.0. Radiographics. 2011 Nov-Dec;31(7):2093-105. doi: 10.1148/rg.317115050. PMID: 22084190.
Copy Download .nbib Format: NLM
Long-Term Outcomes of Single-Vessel Percutaneous Coronary Intervention on Culprit Vessel vs. Multivessel Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Multivessel Coronary Artery Disease.

Circulation journal : official journal of the Japanese Circulation Society

Li T, Jia S, Liu Y, Yao Y, Song Y, Tang X, Zhao X, Gao R, Yang Y, Xu B, Gao Z, Yuan J.
PMID: 33431719
Circ J. 2021 Jan 25;85(2):185-193. doi: 10.1253/circj.CJ-20-0369. Epub 2021 Jan 09.

BACKGROUND: The optimal percutaneous coronary intervention (PCI) strategy for multivessel lesions in the setting of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) remains controversial. This study sought to compare long-term prognosis between single-vessel PCI (SV-PCI) and multivessel PCI (MV-PCI) in...

Cite
Li T, Jia S, Liu Y, et al. Long-Term Outcomes of Single-Vessel Percutaneous Coronary Intervention on Culprit Vessel vs. Multivessel Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Multivessel Coronary Artery Disease. Circ J. 2021;85(2):185-193doi: 10.1253/circj.CJ-20-0369.
Li, T., Jia, S., Liu, Y., Yao, Y., Song, Y., Tang, X., Zhao, X., Gao, R., Yang, Y., Xu, B., Gao, Z., & Yuan, J. (2021). Long-Term Outcomes of Single-Vessel Percutaneous Coronary Intervention on Culprit Vessel vs. Multivessel Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Multivessel Coronary Artery Disease. Circulation journal : official journal of the Japanese Circulation Society, 85(2), 185-193. https://doi.org/10.1253/circj.CJ-20-0369
Li, Tianyu, et al. "Long-Term Outcomes of Single-Vessel Percutaneous Coronary Intervention on Culprit Vessel vs. Multivessel Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Multivessel Coronary Artery Disease." Circulation journal : official journal of the Japanese Circulation Society vol. 85,2 (2021): 185-193. doi: https://doi.org/10.1253/circj.CJ-20-0369
Li T, Jia S, Liu Y, Yao Y, Song Y, Tang X, Zhao X, Gao R, Yang Y, Xu B, Gao Z, Yuan J. Long-Term Outcomes of Single-Vessel Percutaneous Coronary Intervention on Culprit Vessel vs. Multivessel Percutaneous Coronary Intervention in Non-ST-Segment Elevation Acute Coronary Syndrome Patients With Multivessel Coronary Artery Disease. Circ J. 2021 Jan 25;85(2):185-193. doi: 10.1253/circj.CJ-20-0369. Epub 2021 Jan 09. PMID: 33431719.
Copy Download .nbib Format: NLM
Three ways of understanding development as a teacher.

European journal of dental education : official journal of the Association for Dental Education in Europe

Stenfors-Hayes T, Hult H, Dahlgren LO.
PMID: 22251339
Eur J Dent Educ. 2012 Feb;16(1):e151-7. doi: 10.1111/j.1600-0579.2011.00690.x. Epub 2011 May 10.

The demands on faculty in terms of teaching are increasing, but until recently there has been little discussion of how faculty perceive that development as a teacher can be achieved or what approaches they use or suggest themselves. The...

Cite
Stenfors-Hayes T, Hult H, Dahlgren LO. Three ways of understanding development as a teacher. Eur J Dent Educ. 2011;16(1):e151-7doi: 10.1111/j.1600-0579.2011.00690.x.
Stenfors-Hayes, T., Hult, H., & Dahlgren, L. O. (2012). Three ways of understanding development as a teacher. European journal of dental education : official journal of the Association for Dental Education in Europe, 16(1), e151-7. https://doi.org/10.1111/j.1600-0579.2011.00690.x
Stenfors-Hayes, T, et al. "Three ways of understanding development as a teacher." European journal of dental education : official journal of the Association for Dental Education in Europe vol. 16,1 (2012): e151-7. doi: https://doi.org/10.1111/j.1600-0579.2011.00690.x
Stenfors-Hayes T, Hult H, Dahlgren LO. Three ways of understanding development as a teacher. Eur J Dent Educ. 2012 Feb;16(1):e151-7. doi: 10.1111/j.1600-0579.2011.00690.x. Epub 2011 May 10. PMID: 22251339.
Copy Download .nbib Format: NLM
Quantifying surgeon's contribution to team effectiveness on a mixed team with a junior surgeon.

Surgery

Zheng B, Swanström LL, Meneghetti A, Panton ON, Qayumi AK.
PMID: 21514612
Surgery. 2011 Jun;149(6):761-5. doi: 10.1016/j.surg.2010.11.013. Epub 2011 Apr 22.

BACKGROUND: A surgical team often consists of an experienced surgeon and surgeons in training. This project quantified the contribution of the experienced surgeon to the teamwork in a team comprised of 1 experienced and 1 novice surgeon (Mixed Team).METHODS:...

Cite
Zheng B, Swanström LL, Meneghetti A, et al. Quantifying surgeon's contribution to team effectiveness on a mixed team with a junior surgeon. Surgery. 2011;149(6):761-5doi: 10.1016/j.surg.2010.11.013.
Zheng, B., Swanström, L. L., Meneghetti, A., Panton, O. N., & Qayumi, A. K. (2011). Quantifying surgeon's contribution to team effectiveness on a mixed team with a junior surgeon. Surgery, 149(6), 761-5. https://doi.org/10.1016/j.surg.2010.11.013
Zheng, Bin, et al. "Quantifying surgeon's contribution to team effectiveness on a mixed team with a junior surgeon." Surgery vol. 149,6 (2011): 761-5. doi: https://doi.org/10.1016/j.surg.2010.11.013
Zheng B, Swanström LL, Meneghetti A, Panton ON, Qayumi AK. Quantifying surgeon's contribution to team effectiveness on a mixed team with a junior surgeon. Surgery. 2011 Jun;149(6):761-5. doi: 10.1016/j.surg.2010.11.013. Epub 2011 Apr 22. PMID: 21514612.
Copy Download .nbib Format: NLM
Learning in the simulated setting: a comparison of expert-, peer-, and computer-assisted learning.

Academic medicine : journal of the Association of American Medical Colleges

Walsh CM, Rose DN, Dubrowski A, Ling SC, Grierson LE, Backstein D, Carnahan H.
PMID: 21955760
Acad Med. 2011 Oct;86(10):S12-6. doi: 10.1097/ACM.0b013e31822a72c7.

PURPOSE: To compare the effectiveness of expert-assisted learning (EAL), peer-assisted learning (PAL), and computer-assisted learning (CAL) on participants' procedural skills acquisition in the simulated setting.METHOD: Sixty medical and nursing students practiced urinary catheterization in an expert-, peer- or computer-assisted,...

Cite
Walsh CM, Rose DN, Dubrowski A, et al. Learning in the simulated setting: a comparison of expert-, peer-, and computer-assisted learning. Acad Med. 2011;86(10):S12-6doi: 10.1097/ACM.0b013e31822a72c7.
Walsh, C. M., Rose, D. N., Dubrowski, A., Ling, S. C., Grierson, L. E., Backstein, D., & Carnahan, H. (2011). Learning in the simulated setting: a comparison of expert-, peer-, and computer-assisted learning. Academic medicine : journal of the Association of American Medical Colleges, 86(10), S12-6. https://doi.org/10.1097/ACM.0b013e31822a72c7
Walsh, Catharine M, et al. "Learning in the simulated setting: a comparison of expert-, peer-, and computer-assisted learning." Academic medicine : journal of the Association of American Medical Colleges vol. 86,10 (2011): S12-6. doi: https://doi.org/10.1097/ACM.0b013e31822a72c7
Walsh CM, Rose DN, Dubrowski A, Ling SC, Grierson LE, Backstein D, Carnahan H. Learning in the simulated setting: a comparison of expert-, peer-, and computer-assisted learning. Acad Med. 2011 Oct;86(10):S12-6. doi: 10.1097/ACM.0b013e31822a72c7. PMID: 21955760.
Copy Download .nbib Format: NLM
Bias in reporting clinical trials.

British journal of clinical pharmacology

Bardy AH.
PMID: 9723823
Br J Clin Pharmacol. 1998 Aug;46(2):147-50. doi: 10.1046/j.1365-2125.1998.00759.x.

AIMS: The primary aim of the present study was to identify possible occurrence of selective reporting of the results of clinical trials to the Finnish National Agency for Medicines. Selective reporting may lead to poorly informed action or inaction...

Cite
Bardy AH. Bias in reporting clinical trials. Br J Clin Pharmacol. 1998;46(2):147-50doi: 10.1046/j.1365-2125.1998.00759.x.
Bardy, A. H. (1998). Bias in reporting clinical trials. British journal of clinical pharmacology, 46(2), 147-50. https://doi.org/10.1046/j.1365-2125.1998.00759.x
Bardy, A H. "Bias in reporting clinical trials." British journal of clinical pharmacology vol. 46,2 (1998): 147-50. doi: https://doi.org/10.1046/j.1365-2125.1998.00759.x
Bardy AH. Bias in reporting clinical trials. Br J Clin Pharmacol. 1998 Aug;46(2):147-50. doi: 10.1046/j.1365-2125.1998.00759.x. PMID: 9723823; PMCID: PMC1873669.
Copy Download .nbib Format: NLM
Comparative evaluation of tractography-based direct targeting and atlas-based indirect targeting of the ventral intermediate (Vim) nucleus in MRgFUS thalamotomy.

Scientific reports

Bruno F, Catalucci A, Varrassi M, Arrigoni F, Sucapane P, Cerone D, Pistoia F, Torlone S, Tommasino E, De Santis L, Barile A, Ricci A, Marini C, Splendiani A, Masciocchi C.
PMID: 34188190
Sci Rep. 2021 Jun 29;11(1):13538. doi: 10.1038/s41598-021-93058-2.

To analyze and compare direct and indirect targeting of the Vim for MRgFUS thalamotomy. We retrospectively evaluated 21 patients who underwent unilateral MRgFUS Vim ablation and required targeting repositioning during the procedures. For each patient, in the three spatial...

Cite
Bruno F, Catalucci A, Varrassi M, et al. Comparative evaluation of tractography-based direct targeting and atlas-based indirect targeting of the ventral intermediate (Vim) nucleus in MRgFUS thalamotomy. Sci Rep. 2021;11(1):13538doi: 10.1038/s41598-021-93058-2.
Bruno, F., Catalucci, A., Varrassi, M., Arrigoni, F., Sucapane, P., Cerone, D., Pistoia, F., Torlone, S., Tommasino, E., De Santis, L., Barile, A., Ricci, A., Marini, C., Splendiani, A., & Masciocchi, C. (2021). Comparative evaluation of tractography-based direct targeting and atlas-based indirect targeting of the ventral intermediate (Vim) nucleus in MRgFUS thalamotomy. Scientific reports, 11(1), 13538. https://doi.org/10.1038/s41598-021-93058-2
Bruno, Federico, et al. "Comparative evaluation of tractography-based direct targeting and atlas-based indirect targeting of the ventral intermediate (Vim) nucleus in MRgFUS thalamotomy." Scientific reports vol. 11,1 (2021): 13538. doi: https://doi.org/10.1038/s41598-021-93058-2
Bruno F, Catalucci A, Varrassi M, Arrigoni F, Sucapane P, Cerone D, Pistoia F, Torlone S, Tommasino E, De Santis L, Barile A, Ricci A, Marini C, Splendiani A, Masciocchi C. Comparative evaluation of tractography-based direct targeting and atlas-based indirect targeting of the ventral intermediate (Vim) nucleus in MRgFUS thalamotomy. Sci Rep. 2021 Jun 29;11(1):13538. doi: 10.1038/s41598-021-93058-2. PMID: 34188190; PMCID: PMC8241849.
Copy Download .nbib Format: NLM
Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes?.

The Journal of urology

Nguyen DD, Haeuser L, Paciotti M, Reitblat C, Cellini J, Lipsitz SR, Kibel AS, Choudhury AD, Cone EB, Trinh QD.
PMID: 33443458
J Urol. 2021 May;205(5):1263-1274. doi: 10.1097/JU.0000000000001601. Epub 2021 Jan 14.

PURPOSE: Prostate cancer is most commonly an indolent disease, especially when detected at a localized stage. Unlike other tumors that may benefit from timely receipt of definitive therapy, it is generally accepted that treatment delays for localized prostate cancer...

Cite
Nguyen DD, Haeuser L, Paciotti M, et al. Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes?. J Urol. 2021;205(5):1263-1274doi: 10.1097/JU.0000000000001601.
Nguyen, D. D., Haeuser, L., Paciotti, M., Reitblat, C., Cellini, J., Lipsitz, S. R., Kibel, A. S., Choudhury, A. D., Cone, E. B., & Trinh, Q. D. (2021). Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes?. The Journal of urology, 205(5), 1263-1274. https://doi.org/10.1097/JU.0000000000001601
Nguyen, David-Dan, et al. "Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes?." The Journal of urology vol. 205,5 (2021): 1263-1274. doi: https://doi.org/10.1097/JU.0000000000001601
Nguyen DD, Haeuser L, Paciotti M, Reitblat C, Cellini J, Lipsitz SR, Kibel AS, Choudhury AD, Cone EB, Trinh QD. Systematic Review of Time to Definitive Treatment for Intermediate Risk and High Risk Prostate Cancer: Are Delays Associated with Worse Outcomes?. J Urol. 2021 May;205(5):1263-1274. doi: 10.1097/JU.0000000000001601. Epub 2021 Jan 14. PMID: 33443458.
Copy Download .nbib Format: NLM
Showing 2689 to 2700 of 2709 entries